Convatec in the news
trusted medical solutions provider
Tamtam found 20 recent articles about Convatec.
- ConvaTec Share Price: 255.80p, Up 0.95% Nov 12
ConvaTec Group's stock price increased by 0.95% on November 12, 2026, reaching 255.80 pence with significantly high trading volume.
- How Will Convatec (LSE:CTEC) Manage Its Finance Chief Handover To Jill McConnell?
Convatec appointed Jill McConnell as chief financial officer designate, with current CFO Fiona Ryder to depart after the full-year results, while also announcing other board changes.
- Convatec Group (LSE:CTEC), Why Is Its Latest Update Drawing Attention?
Convatec Group announced a CFO transition and analysts consider its stock undervalued despite a high P/E ratio, driven by strong market demand and product expansion.
- Convatec Group (LSE:CTEC) CFO Handover Puts Chronic Care Growth and Valuation in Focus
Convatec Group has appointed Jill McConnell as its new CFO Designate, initiating a planned leadership transition while the company navigates chronic care market growth, new product launches, and ongoing valuation debates.
- Why Does Convatec Group (LSE:CTEC) Matter in the Current UK Market?
Convatec Group's market relevance stems from its chronic-care medical products, with focus on recurring patient demand and specialist portfolio, while managing manufacturing and reimbursement risks.
- CFO Succession Might Change The Case For Investing In Convatec Group (LSE:CTEC)
Convatec Group has appointed Jill McConnell as its future CFO, signaling a focus on continuity and strengthening financial leadership amid ongoing investments and operational improvements.
- Weekly Recap: CFO transition and board appointments
Convatec Group Plc announced a CFO transition and new board appointments.
- Why Is Convatec (LSE:CTEC) Back On Radar This Week After Naming A New Finance Chief?
Convatec announced Jill McConnell as the new finance chief, replacing Fiona Ryder, maintaining stability in its chronic care product business.
- Convatec Recognized With Two Prestigious Vizient® Supplier Excellence Awards
Convatec was honored with two prestigious Vizient Supplier Excellence Awards for its contributions to healthcare.
- JP Morgan says ConvaTec guidance looks increasingly secure ahead of trading update
JP Morgan reaffirms 'overweight' rating on ConvaTec, projecting secure 2026 earnings and an attractive valuation compared to Coloplast.
- Is Convatec Group (LSE:CTEC) Trading Below Fair Value On Cash Flow?
Convatec Group's stock price, despite a 29.0% 5-year gain, appears undervalued based on its strong free cash flow generation and future growth projections according to a Discounted Cash Flow analysis.
- Inventor sues employers for £366m over work on 'high-tech plaster' that made billions
A former Convatec chemist is suing the company for £366 million, claiming his patented work on high-tech wound dressings, specifically Aquacel, generated billions in profit for them.
- Convatec (LSE:CTEC) Accelerate Strategy Sets Out a Path to Faster Organic Growth With FTSE 100 in Focus
Convatec introduced its Accelerate strategy to boost organic growth through innovation and efficiency in chronic care markets.
- Is Convatec Group (LSE:CTEC) Still Counting On A Stronger Second Half In Its Recovery Story As FTSE 100 Holds Steady?
Convatec Group reaffirmed its full-year guidance despite an InnovaMatrix drag on reported growth, with recovery anticipated in the second half.
- ConvaTec Group advances Friday, outperforms market
ConvaTec Group's shares increased by 3.29% to 2.20 on Friday, outperforming the rising FTSE 100 Index.
- ConvaTec reported ostomy findings and ConvaTec stock fell 1.54 percent
ConvaTec stock fell after releasing new ostomy-care research showing high rates of leakage and skin problems among patients, despite a 6.6% increase in continence care revenue for the first half of 2026.
- After years-long turnaround, Convatec’s new CEO plans R&D push
Convatec's new CEO Jonny Mason is focusing on R&D and product launches in infusion, wound, ostomy, and continence care after completing a multi-year business turnaround.
- Convatec Survey Challenges Assumptions About Leakage in Ostomy Care
Convatec's new global survey emphasizes the critical role of peristomal skin health in preventing leakage and improving confidence for people with an ostomy, highlighting a gap in current care.
- REG - Convatec Group PLC - Holding(s) in Company
FIL Limited notified Convatec Group PLC of a slight decrease in its major holdings, now holding 4.959000% of voting rights as of September 30, 2026.
- Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize
Convatec introduced Cure Aqua™, a new ready-to-use hydrophilic catheter, in the US and Canada to enhance comfort and simplify self-catheterization for users.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Convatec?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies